Trial · NCT07907744
Plasma Exeresis Plus NB-UVB Versus NB-UVB Alone for Stable Vitiligo
NCT07907744, Not applicable, Active not recruiting, University of Faisalabad
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Plasma Exeresis Plus NB-UVB Versus NB-UVB Alone for Stable Vitiligo. Trials, record NCT07907744. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907744
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Plasma Exeresis Plus NB-UVB Versus NB-UVB Alone for Stable Vitiligo
- NCT number
- NCT07907744
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 70 participants, actual
- Lead sponsor
- University of Faisalabad
- Conditions
- Vitiligo
- Interventions
- Plasma Exeresis, Narrowband Ultraviolet B (NB-UVB) Phototherapy
- First posted
- 2026-10-30
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Vitiligo Area Scoring Index (VASI) from Baseline to Week 24 | Baseline to Week 24 | Treatment efficacy will be assessed by measuring the change in the Vitiligo Area Scoring Index (VASI) from baseline to Week 24. The VASI is a validated clinical scoring system used to assess the extent of vitiligo and the degree of depigmentation. The score is based on the percentage of body surface area affected by vitiligo and the degree of depigmentation within the affected areas. Higher VASI scores indicate greater disease severity, whereas lower scores indicate less extensive vitiligo and improvement. The VASI score has a theoretical minimum of 0, indicating no vitiligo, and a maximum of 100, representing complete depigmentation of the entire body surface area. A reduction in VASI score from baseline to Week 24 indicates improvement in vitiligo severity. A reduction of 50% or more from baseline will be considered a clinically significant improvement. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07907744
GET https://conductscience.org/api/trials/v1/NCT07907744/registered